iBio (NASDAQ:IBIO) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of $-0.09,…
iBio (NASDAQ:IBIO) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.09, missing the consensus estimate of $-0.07 by $0.02 per share. Revenue came in at , missing the estimate of $60.0K.
iBio's stock moved following the earnings release. The stock currently trades at $2.13 with a market capitalization of $39.7M.
Current market data
NASDAQ · IBIO
$1.45
Unchanged: $0.00 · 0.00%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
